These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2695155)

  • 1. Induction of labour after fetal death: a randomized controlled trial of two prostaglandin regimens.
    Kanhai HH; Keirse MJ
    Br J Obstet Gynaecol; 1989 Dec; 96(12):1400-4. PubMed ID: 2695155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
    Kanhai HH; Keirse MJ
    Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine rupture after induction of labour for intrauterine death using the prostaglandin E2 analogue sulprostone.
    Prasad RN; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):282-3. PubMed ID: 1445147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dinoprostone priming of the cervix prior to termination of midgestation pregnancy with sulprostone.
    Rietberg CC; Lotgering FK; Huikeshoven FJ
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):157-60. PubMed ID: 7641968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of sulprostone, a prostaglandin E2 derivative, in intrauterine fetal death and therapeutic abortion.
    Lippert TH; Briel RC
    Prostaglandins Med; 1980 Oct; 5(4):259-65. PubMed ID: 7443872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rupture of a healthy uterus in a prostaglandin-induced abortion in the second trimester].
    Larue L; Marpeau L; Percque M; Castiel J; Guettier X; Maghioracos P; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):269-72. PubMed ID: 2071873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel.
    Danielian P; Porter B; Ferri N; Summers J; Templeton A
    Br J Obstet Gynaecol; 1999 Aug; 106(8):793-7. PubMed ID: 10453828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulprostone, a synthetic PGE2 analogue in first trimester abortion. Clinical efficacy and influence on serum progesterone of different single doses.
    Larsson B; Jonasson A; Carlström K
    Gynecol Obstet Invest; 1990; 29(1):10-2. PubMed ID: 2351329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labor characteristics of uncomplicated prolonged pregnancies after induction with intracervical prostaglandin E2 gel versus intravenous oxytocin.
    Papageorgiou I; Tsionou C; Minaretzis D; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1992; 34(2):92-6. PubMed ID: 1398272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol for induction of labour: a systematic review.
    Hofmeyr GJ; Gülmezoglu AM; Alfirevic Z
    Br J Obstet Gynaecol; 1999 Aug; 106(8):798-803. PubMed ID: 10453829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular administration of 15-methyl-prostaglandin F(2alpha) for induction of labour in patients with intrauterine fetal death or an anencephalic fetus.
    Ylikorkala O; Kirkinen P; Järvinen PA
    Br J Obstet Gynaecol; 1976 Jun; 83(6):502-4. PubMed ID: 1276108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
    Gruber WS; Baumgarten K
    Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.